News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EnBioTec And Timtec Inc. Entered Into Agreement To Develop Nuclear Receptor Based Lead Chemicals


9/11/2006 11:02:28 AM

Tokyo, Japan - EnBioTec Laboratories Co., Ltd. based in Tokyo Japan has entered into an agreement with TimTec Inc. to co-develop nuclear receptor based lead compounds for drug discovery. EnBioTec Laboratories has developed Receptor Cofactor Assay System (RCAS) to evaluate interaction between nuclear hormone receptor and co-factor in the presence of compound. The system is cell-free and highly sensitive, and is able to distinguish between agonist and antagonist.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES